"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Thallous Chloride Tl-201 Injection
Following the administration of Thallous Chloride Tl-201, adverse anaphylactoid reactions have been reported (characterized by cardiovascular, respiratory and cutaneous symptoms), some severe enough to require treatment. Hypotension, pruritus, flushing, and diffuse rash which responds to antihistamines have been reported. Other reported events include itching, nausea/vomiting, mild diarrhea, tremor, shortness of breath, chills, fever, conjunctivitis, sweating, and blurred vision.
Adverse events, some of which were serious, have also been reported in patients who have undergone thallium pharmacologic testing (see WARNINGS). Please refer to the package inserts of approved pharmacologic stress agents for more detailed information on those adverse reactions.
Read the Thallous Chloride Tl-201 Injection (thallous chloride) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 10/21/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Thallous Chloride Tl-201 Injection Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.